{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T11:46:51Z","timestamp":1776426411726,"version":"3.51.2"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T00:00:00Z","timestamp":1603411200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T00:00:00Z","timestamp":1603411200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s00415-020-10202-0","type":"journal-article","created":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T16:02:41Z","timestamp":1603468961000},"page":"851-859","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Neurolymphomatosis: a single-center experience of neuromuscular manifestations, treatments, and outcomes"],"prefix":"10.1007","volume":"268","author":[{"given":"Jisun","family":"Jeong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sun Woong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8261-7199","authenticated-orcid":false,"given":"Duk Hyun","family":"Sung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,23]]},"reference":[{"key":"10202_CR1","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1136\/jnnp.2007.125930","volume":"79","author":"K Viala","year":"2008","unstructured":"Viala K, Behin A, Maisonobe T, Leger JM, Stojkovic T, Davi F, Leblond V, Bouche P (2008) Neuropathy in lymphoma: a relationship between the pattern of neuropathy, type of lymphoma and prognosis? J Neurol Neurosurg Psychiatry 79:778\u2013782. https:\/\/doi.org\/10.1136\/jnnp.2007.125930","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10202_CR2","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/1754-9485.12321","volume":"60","author":"AT Lim","year":"2016","unstructured":"Lim AT, Clucas D, Khoo C, Parameswaran BK, Lau E (2016) Neurolymphomatosis: MRI and (18) FDG-PET features. J Med Imaging Radiat Oncol 60:92\u201395. https:\/\/doi.org\/10.1111\/1754-9485.12321","journal-title":"J Med Imaging Radiat Oncol"},{"key":"10202_CR3","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1212\/wnl.42.6.1136","volume":"42","author":"R Diaz-Arrastia","year":"1992","unstructured":"Diaz-Arrastia R, Younger DS, Hair L, Inghirami G, Hays AP, Knowles DM, Odel JG, Fetell MR, Lovelace RE, Rowland LP (1992) Neurolymphomatosis: a clinicopathologic syndrome re-emerges. Neurology 42:1136\u20131141. https:\/\/doi.org\/10.1212\/wnl.42.6.1136","journal-title":"Neurology"},{"key":"10202_CR4","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1093\/neuonc\/nop021","volume":"5","author":"JM Baehring","year":"2003","unstructured":"Baehring JM, Damek D, Martin EC, Betensky RA, Hochberg FH (2003) Neurolymphomatosis. Neuro Oncol 5:104\u2013115. https:\/\/doi.org\/10.1093\/neuonc\/nop021","journal-title":"Neuro Oncol"},{"key":"10202_CR5","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.jns.2014.05.058","volume":"343","author":"C Kamiya-Matsuoka","year":"2014","unstructured":"Kamiya-Matsuoka C, Shroff S, Gildersleeve K, Hormozdi B, Manning JT, Woodman KH (2014) Neurolymphomatosis: a case series of clinical manifestations, treatments, and outcomes. J Neurol Sci 343:144\u2013148. https:\/\/doi.org\/10.1016\/j.jns.2014.05.058","journal-title":"J Neurol Sci"},{"key":"10202_CR6","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1093\/neuonc\/nop021","volume":"12","author":"HK Gan","year":"2010","unstructured":"Gan HK, Azad A, Cher L, Mitchell PL (2010) Neurolymphomatosis: diagnosis, management, and outcomes in patients treated with rituximab. Neuro Oncol 12:212\u2013215. https:\/\/doi.org\/10.1093\/neuonc\/nop021","journal-title":"Neuro Oncol"},{"key":"10202_CR7","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1097\/PPO.0b013e31826c5ad5","volume":"18","author":"JM Baehring","year":"2012","unstructured":"Baehring JM, Batchelor TT (2012) Diagnosis and management of neurolymphomatosis. Cancer J 18:463\u2013468. https:\/\/doi.org\/10.1097\/PPO.0b013e31826c5ad5","journal-title":"Cancer J"},{"key":"10202_CR8","doi-asserted-by":"publisher","first-page":"5005","DOI":"10.1182\/blood-2009-12-258210","volume":"115","author":"S Grisariu","year":"2010","unstructured":"Grisariu S, Avni B, Batchelor TT, van den Bent MJ, Bokstein F, Schiff D, Kuittinen O, Chamberlain MC, Roth P, Nemets A, Shalom E, Ben-Yehuda D, Siegal T, International Primary CNSLCG (2010) Neurolymphomatosis: an International Primary CNS Lymphoma Collaborative Group report. Blood 115:5005\u20135011. https:\/\/doi.org\/10.1182\/blood-2009-12-258210","journal-title":"Blood"},{"key":"10202_CR9","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.1080\/10428194.2017.1312376","volume":"58","author":"JM Byun","year":"2017","unstructured":"Byun JM, Kim KH, Kim M, Kim TM, Jeon YK, Park JH, Paik JH, Lee JM, Lee HY, Lee JS, Heo DS, Lee JO (2017) Diagnosis of secondary peripheral neurolymphomatosis: a multi-center experience. Leuk Lymphoma 58:2624\u20132632. https:\/\/doi.org\/10.1080\/10428194.2017.1312376","journal-title":"Leuk Lymphoma"},{"key":"10202_CR10","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1177\/014107689408700915","volume":"87","author":"RA Hughes","year":"1994","unstructured":"Hughes RA, Britton T, Richards M (1994) Effects of lymphoma on the peripheral nervous system. J R Soc Med 87:526\u2013530","journal-title":"J R Soc Med"},{"key":"10202_CR11","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/BF00445779","volume":"370","author":"K Jellinger","year":"1976","unstructured":"Jellinger K, Radiaszkiewicz T (1976) Involvement of the central nervous system in malignant lymphomas. Virchows Arch A Pathol Anat Histol 370:345\u2013362. https:\/\/doi.org\/10.1007\/BF00445779","journal-title":"Virchows Arch A Pathol Anat Histol"},{"key":"10202_CR12","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jns.2014.04.030","volume":"342","author":"S Lagarde","year":"2014","unstructured":"Lagarde S, Tabouret E, Matta M, Franques J, Attarian S, Pouget J, Maues De Paula A, Figarella-Branger D, Dory-Lautrec P, Chinot O, Barrie M (2014) Primary neurolymphomatosis diagnosis and treatment: a retrospective study. J Neurol Sci 342:178\u2013181. https:\/\/doi.org\/10.1016\/j.jns.2014.04.030","journal-title":"J Neurol Sci"},{"key":"10202_CR13","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1007\/s00415-016-8190-4","volume":"263","author":"H Kinoshita","year":"2016","unstructured":"Kinoshita H, Yamakado H, Kitano T, Kitamura A, Yamashita H, Miyamoto M, Hitomi T, Okada T, Nakamoto Y, Sawamoto N, Takaori-Kondo A, Takahashi R (2016) Diagnostic utility of FDG-PET in neurolymphomatosis: report of five cases. J Neurol 263:1719\u20131726. https:\/\/doi.org\/10.1007\/s00415-016-8190-4","journal-title":"J Neurol"},{"key":"10202_CR14","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1097\/MNM.0b013e3283561881","volume":"33","author":"LP Salm","year":"2012","unstructured":"Salm LP, Van der Hiel B, Stokkel MP (2012) Increasing importance of 18F-FDG PET in the diagnosis of neurolymphomatosis. Nucl Med Commun 33:907\u2013916. https:\/\/doi.org\/10.1097\/MNM.0b013e3283561881","journal-title":"Nucl Med Commun"},{"key":"10202_CR15","doi-asserted-by":"publisher","first-page":"4512","DOI":"10.1002\/cncr.26090","volume":"117","author":"K Matsue","year":"2011","unstructured":"Matsue K, Hayama BY, Iwama K, Koyama T, Fujiwara H, Yamakura M, Takeuchi M, O'Uchi T (2011) High frequency of neurolymphomatosis as a relapse disease of intravascular large B-cell lymphoma. Cancer 117:4512\u20134521. https:\/\/doi.org\/10.1002\/cncr.26090","journal-title":"Cancer"},{"key":"10202_CR16","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1080\/10428194.2017.1352096","volume":"59","author":"T Davidson","year":"2018","unstructured":"Davidson T, Kedmi M, Avigdor A, Komisar O, Chikman B, Lidar M, Goshen E, Tzila Zwas S, Ben-Haim S (2018) FDG PET-CT evaluation in neurolymphomatosis: imaging characteristics and clinical outcomes. Leuk Lymphoma 59:348\u2013356. https:\/\/doi.org\/10.1080\/10428194.2017.1352096","journal-title":"Leuk Lymphoma"},{"key":"10202_CR17","first-page":"57","volume":"2","author":"NX Canh","year":"2014","unstructured":"Canh NX, Tan NV, Tung TT, Son NT, Maurea S (2014) (18)F-FDG PET\/CT in neurolymphomatosis: report of 3 cases. Asia Ocean J Nucl Med Biol 2:57\u201364","journal-title":"Asia Ocean J Nucl Med Biol"},{"key":"10202_CR18","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1136\/jnnp.2006.087577","volume":"77","author":"MJ Descamps","year":"2006","unstructured":"Descamps MJ, Barrett L, Groves M, Yung L, Birch R, Murray NM, Linch DC, Lunn MP, Reilly MM (2006) Primary sciatic nerve lymphoma: a case report and review of the literature. J Neurol Neurosurg Psychiatry 77:1087\u20131089. https:\/\/doi.org\/10.1136\/jnnp.2006.087577","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10202_CR19","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/978-1-60761-938-3_6","volume":"686","author":"A Weerasuriya","year":"2011","unstructured":"Weerasuriya A, Mizisin AP (2011) The blood\u2013nerve barrier: structure and functional significance. Methods Mol Biol 686:149\u2013173. https:\/\/doi.org\/10.1007\/978-1-60761-938-3_6","journal-title":"Methods Mol Biol"},{"key":"10202_CR20","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1227\/00006123-199506000-00024","volume":"36","author":"M Kanamori","year":"1995","unstructured":"Kanamori M, Matsui H, Yudoh K (1995) Solitary T-cell lymphoma of the sciatic nerve: case report. Neurosurgery 36:1203\u20131205. https:\/\/doi.org\/10.1227\/00006123-199506000-00024","journal-title":"Neurosurgery"},{"key":"10202_CR21","doi-asserted-by":"publisher","unstructured":"(1995) Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 8-1995. A 75-year-old man with multiple cranial-nerve defects and weakness and pain in the extremities. N Engl J Med 332:730\u2013737. https:\/\/doi.org\/10.1056\/NEJM199503163321108","DOI":"10.1056\/NEJM199503163321108"},{"key":"10202_CR22","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/978-3-662-08456-4_11","volume":"6","author":"HM Zimmerman","year":"1975","unstructured":"Zimmerman HM (1975) Malignant lymphomas of the nervous system. Acta Neuropathol Suppl Suppl 6:69\u201374. https:\/\/doi.org\/10.1007\/978-3-662-08456-4_11","journal-title":"Acta Neuropathol Suppl Suppl"},{"key":"10202_CR23","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2147\/JPR.S26603","volume":"5","author":"D Sapunar","year":"2012","unstructured":"Sapunar D, Kostic S, Banozic A, Puljak L (2012) Dorsal root ganglion\u2014a potential new therapeutic target for neuropathic pain. J Pain Res 5:31\u201338. https:\/\/doi.org\/10.2147\/JPR.S26603","journal-title":"J Pain Res"},{"key":"10202_CR24","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1097\/00000542-200607000-00024","volume":"105","author":"SE Abram","year":"2006","unstructured":"Abram SE, Yi J, Fuchs A, Hogan QH (2006) Permeability of injured and intact peripheral nerves and dorsal root ganglia. Anesthesiology 105:146\u2013153. https:\/\/doi.org\/10.1097\/00000542-200607000-00024","journal-title":"Anesthesiology"},{"key":"10202_CR25","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/BF00690507","volume":"10","author":"Y Olsson","year":"1968","unstructured":"Olsson Y (1968) Topographical differences in the vascular permeability of the peripheral nervous system. Acta Neuropathol 10:26\u201333. https:\/\/doi.org\/10.1007\/BF00690507","journal-title":"Acta Neuropathol"},{"key":"10202_CR26","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/cne.901910106","volume":"191","author":"LT Malmgren","year":"1980","unstructured":"Malmgren LT, Olsson Y (1980) Differences between the peripheral and the central nervous system in permeability to sodium fluorescein. J Comp Neurol 191:103\u2013107. https:\/\/doi.org\/10.1002\/cne.901910106","journal-title":"J Comp Neurol"},{"key":"10202_CR27","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1182\/blood.V79.9.2432.2432","volume":"79","author":"WF Kern","year":"1992","unstructured":"Kern WF, Spier CM, Hanneman EH, Miller TP, Matzner M, Grogan TM (1992) Neural cell adhesion molecule-positive peripheral T-cell lymphoma: a rare variant with a propensity for unusual sites of involvement. Blood 79:2432\u20132437","journal-title":"Blood"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-020-10202-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-020-10202-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-020-10202-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T12:41:15Z","timestamp":1669293675000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-020-10202-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,23]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["10202"],"URL":"https:\/\/doi.org\/10.1007\/s00415-020-10202-0","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,23]]},"assertion":[{"value":"31 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"We did not receive any financial support or other benefits from commercial sources for the work reported in this manuscript, nor did any of the authors have any financial interests with regard to the work that may create a potential conflict of interest or the appearance of one. This work has not been previously presented, submitted, or published in any form or any language. The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional review board and have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}